Email This Release
Bayhill Therapeutics and the Juvenile Diabetes Research Foundation Announce Research Collaboration for the Clinical Development of a Novel Immunotherapeutic DNA Vaccine for Type 1 Diabetes
*
marks required fields
Recipient Name:
*
Recipient Email:
Message:
